ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Brain Cancer
Glioma
Cancer
Recurrence
Astrocytoma
Gliosarcoma

Glioblastoma (GBM) trials near Jacksonville, FL, USA:

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)

FRONTIER Study is a prospective, interventional, single-arm, multi-center, study to assess the safety and technical feasibility of TheraSphere GBM...

Enrolling
Recurrent Glioblastoma
Glioblastoma Multiforme
Device: TheraSphere GBM

Phase 1

Boston Scientific
Boston Scientific

Jacksonville, Florida, United States and 8 other locations

(SOC) will improve survival in adult patients newly diagnosed with glioblastoma (IDH-wt). It will also evaluate the safety of DOC1021 + pIFN...

Enrolling
Glioblastoma (GBM)
Drug: Temodar (Temozolomide)
Biological: DOC1021

Phase 2

Diakonos Oncology Corporation

Jacksonville, Florida, United States and 13 other locations

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Regorafenib
Drug: Temozolomide

Phase 2, Phase 3

Global Coalition for Adaptive Research

Jacksonville, Florida, United States and 62 other locations

Optune® together with maintenance TMZ and placebo in newly diagnosed Glioblastoma (GBM) patients. The primary objective of the stud...

Enrolling
Glioblastoma
Drug: Temozolomide
Drug: Placebo

Phase 3

NovoCure
NovoCure

Jacksonville, Florida, United States and 80 other locations

The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...

Active, not recruiting
Glioblastoma
Combination Product: IGV-001 Cell Immunotherapy
Drug: SOC: Temozolomide

Phase 2

Imvax

Jacksonville, Florida, United States and 22 other locations

the safety of MT-125 in participants who have been diagnosed with glioblastoma, a primary brain tumor, when administered in combination with...

Not yet enrolling
Glioblastoma (GBM)
Drug: MT-125

Phase 1

Myosin Therapeutics Inc.

Jacksonville, Florida, United States and 2 other locations

are also impermeable to the passage of therapeutic molecules from the blood to the brain. The development of effective treatments against glioblastoma...

Active, not recruiting
Glioblastoma
Recurrent Glioblastoma
Device: SonoCloud-9 (SC9)
Drug: Temozolomide

Phase 3

Carthera

Jacksonville, Florida, United States and 47 other locations

growth factor receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM...

Active, not recruiting
Advanced Non-Small Cell Squamous Lung Cancer
Epidermal Growth Factor Receptor C797S
Drug: silevertinib (BDTX-1535) monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Jacksonville, Florida, United States and 28 other locations

This study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma...

Active, not recruiting
Newly Diagnosed and Recurrent Glioblastoma
Other: Temozolomide
Drug: [68Ga]Ga-NeoB

Phase 1

Novartis
Novartis

Jacksonville, Florida, United States and 22 other locations

This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...

Active, not recruiting
Glioblastoma Multiforme, Adult
Drug: Berubicin
Drug: Lomustine

Phase 2

CNS Pharmaceuticals
CNS Pharmaceuticals

Jacksonville, Florida, United States and 47 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems